Cargando…
Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years
BACKGROUND: The optimal choice of the valve prosthesis in mitral valve replacement (MVR) for infective endocarditis (IE) is controversial and challenging, particularly for younger patients. HYPOTHESIS: The postoperative outcomes of mechanical and biological MVR in IE patients aged 50 to 69 years are...
Autores principales: | Hu, Xingjian, Jiang, Weiwei, Xie, Minghui, Guo, Ruikang, Yim, Wai Yen, Dong, Nianguo, Wang, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533963/ https://www.ncbi.nlm.nih.gov/pubmed/32497339 http://dx.doi.org/10.1002/clc.23407 |
Ejemplares similares
-
Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50–70 Years
por: Yu, Jun, et al.
Publicado: (2022) -
Rare case of Rhizobium radiobacter bioprosthetic mitral valve endocarditis
por: Halas, Ryan, et al.
Publicado: (2017) -
Transseptal Transcatheter Mitral Valve-in-valve Replacement for a Failed Bioprosthetic Mitral Valve
por: Kang, Do-Yoon, et al.
Publicado: (2018) -
Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification
por: Wen, Shuyu, et al.
Publicado: (2022) -
Transcatheter Double Valve-in-Valve Replacement of Aortic and Mitral Bioprosthetic Valves
por: Savoj, Javad, et al.
Publicado: (2019)